By rray, 26 January, 2024 Less likely to benefit advanced HF AF mediated cardiomyopathies suspected significant ventricular scar on CMR severe atrial myopathy dilation fibrosis long standing persistent AF prior failed ablations advanced age or multiple comorbidities
By rray, 26 January, 2024 Those likely to benefit earlier stage of HF no significant ventricular scar on CMR no mild atrial fibrosis paroxysmal and early persist AF younger pts w o comorbidities
By rray, 26 January, 2024 If HFrEF consider catheter ablation to improve sx QOL and CV outcomes and reduce mortality and HF hospitalizations
By rray, 26 January, 2024 If reduced LV function trial of rhythm control recommended to evaluate if AF is contributing to reduced LV function
By rray, 26 January, 2024 Long term anticoagulation reasonable if nbsp nbsp Treatable GI pulmonary or GU system nbsp nbsp Bleeding related to isolated trauma nbsp nbsp Bleeding related to procedural complications